2025 Baystate APP Education Day

Springfield, MA US
March 28, 2025

Overview

There are approximately 600+ credentialed APP’s at Baystate Health practicing in a number of different divisions. With the continuous changes that are occurring in health care diagnosis and treatments, Advanced Practitioners need frequent updates on the latest medical practices, guidelines and research activities that address local community health concerns and active quality improvement initiatives for Baystate. An educational day will help to provide attendees (APRNs, PAs, MDs, RNs, PharmDs) up-to-date guidelines in health management across all disciplines. This will also provide the opportunity for professional development and networking with colleagues from across Baystate Health.

Target Audience

There are approximately 600+ credentialed APP’s at Baystate Health practicing in a number of different divisions. These practitioners include CNPs, CNMs, CNSs, PAs, and CRNAs. The program will also be open to MDs, pharmacists, and support staff (i.e. RNs, CMAs)

Learning Objectives

 

  • Identify different causes of peripheral edema.
  • Formulate a plan to treat peripheral edema.
  • Identify the risk factors for developing PAD and what diagnostic tests can help confirm your diagnosis.
  • Discuss what constitutes symptomatic peripheral vascular disease and when should patients receive a referral.
  • Discuss the treatment options including both conservative management as well intervention.
  • Identify and describe the available frameworks for serious illness communication
  • Explain the literature on advance care planning and serious illness communication
  • Describe the skills available to practice improving serious illness communication
  • Identify hospitalized patients with opioid use disorder and complex pain conditions by recognizing key clinical and behavioral indicators.
  • Develop an evidence-based management plan that includes appropriate pain control strategies and medications while addressing opioid use disorder.
  • Implement effective discharge and transition strategies to ensure continuity of care, minimize relapse risk, and optimize long-term pain and addiction management
  • Recognize the scope of resistant hypertension: definition, epidemiology, and etiologies
  • Adapt a pragmatic approach to the management of patients with resistant hypertension
  • Describe the roles of impedance cardiography and renal denervation in the armamentarium of evaluation and treatment of resistant hypertension
  • Recognize current approaches to the use of anticoagulants and when to use left atrial appendage closure
  • Discuss when to pursue rhythm control and better recognize the role of catheter ablation
  • Recognize the various rate control agents and when to use or avoid them.
  • Describe the classification of Heart failure will dictate goal-directed therapy.
  • Discuss the Goal-directed therapy for Heart Failure with Reduced Ejection Fraction HFrEF
  • Identify When to Refer to Specialist
  • Define professional vitality and its impact on professional development
  • Discuss the contextual factors that influence professional vitality
  • Identify ways to enhance one’s professional vitality
  • Describe the “vital signs of the eye”
  • Recall the various important structures of the eye as they relate to common ocular emergencies
  • Recognize 7 important ocular emergencies (plus 1 mimic), how to treat them, and when to call for help
  • Define sepsis and septic shock, explain the pathophysiology and recognize early signs and symptoms.
  • Outline primary treatment protocols for ICU-admitted sepsis patients; Highlight common complications and strategies for managing them.
  • Discuss long-term impacts of sepsis and strategies for outpatient monitoring; Emphasize the importance of early detection, intervention, and preventive measures.
  • Describe the basics of how the lymphatic system functions to move fluid.

 

Course summary
Available credit: 
  • 6.75 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.75 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 6.75 AMA PRA Category 1 Credit™
  • 6.75 ANCC Contact Hours
  • 6.75 IPCE Credit Hour(s)
Course opens: 
03/28/2025
Course expires: 
05/28/2025
Event starts: 
03/28/2025 - 8:00am EDT
Event ends: 
03/28/2025 - 5:00pm EDT

Venue

Baystate Medical Center
759 Chestnut st
Chestnut A & B Conference Room
Springfield, MA 01199
United States

Faculty

FACULTY

Raquel Belforti, DO, MS
Associate Dean of Education
Baystate Health 
Associate Professor 
UMass Chan-Baystate

Paula Brooks, DNP, Course Director
Director of Advanced Practitioners
Baystate Medical Center

Booker Bush, MD
Baystate Medical Center

Colton Conrad, MD
Baystate Medical Center

Barbara Greco, MD
Associate Professor 
UMass Chan-Baystate

Amanda Kravetz, MD
Vascular Surgeon
Baystate Medical Center

Jared Ostroff, PharmD, MBA, BCACP, BCGP, Planner
Program Manager, Ambulatory Pharmacy
Baystate Medical Center

Sharon Woods, PA, Planner
Physician Assistant
Division of Geriatrics
Baystate Medical Center

Adrianne Seiler, MD, Planner
Assistant Professor of Medicine, UMASS Chan-Baystate Health
Chief Clinical Officer
Baystate Medical Center

Barry Rodstein, MD, MPH, MA
Physical Medicine and Rehabilitation, BMC

John P. Marenco, MD, FACC, FHRS
Cardiac electrophysiologist
Pioneer Valley Cardiology

Emily Stout, MSN, RN, AGPCNP-BC
Nurse Practitioner
Palliative Medicine
Baystate Medical Center

Bill Soares, MD
Director of Harm Reduction Services
Dept of Emergency Medicine, Baystate Medical Center
Assistant Professor of Emergency Medicine
UMASS Chan Medical School

Bogdan Tiru, MD
Critical Care Physician
Baystate Medical Center
Assistant Professor 
UMass Chan-Baystate

 

Name of Individual

Individual's Role in Activity

Financial Relationship Disclosure

Discussion of
Unlabeled/Unapproved
Uses of Drugs/Devices
in Presentation?

Paula Brooks, DNPCourse Director, Planner, SpeakerNo relevant relationships with ineligible companies to discloseNo
Jared Ostroff, PharmD, MBA, BCACP, BCGPPlannerNo relevant relationships with ineligible companies to discloseNo
Sharon Woods, PAPlannerNo relevant relationships with ineligible companies to discloseNo
Adrianne Seiler, MDPlanner
No relevant relationships with ineligible companies to disclose
No
Raquel Belforti, DO, MSSpeakerNo relevant relationships with ineligible companies to discloseNo
Booker Bush, MDSpeakerNo relevant relationships with ineligible companies to discloseNo
Colton Conrad, MDSpeakerNo relevant relationships with ineligible companies to discloseNo
Barbara Greco, MDSpeakerAdvisor for MedicaMedix, Chair, Data Monitoring Board for Sanofi, Data Safety Monitoring Board Prokidney React No
Amanda Kravetz, MDSpeakerNo relevant relationships with inelegible companies to discloseNo
Barry Rodstein, MD, MPH, MASpeakerNo relevant relationships with inelegible companies to discloseNo
John P. Marenco, MD, FACC, FHRSSpeakerNo relevant relationships with inelegible companies to discloseNo
Bill Soares, MDSpeakerNo relevant relationships with inelegible companies to discloseNo
Bogdan Tiru, MDSpeakerNo relevant relationships with inelegible companies to discloseNo
Emily Stout, MSN, RN, AGPCNP-BCSpeakerNo relevant relationships with inelegible companies to discloseNo
Faculty Disclosure

Dr. Barbara Greco is a consultant for AA Pharmaceuticals, advisor for MedicaMedix and holds the position of chair for the Data Monitoring Board at Sanofi, as well as the Data Safety Monitoring Board for Prokidney React.
All of the relevant financial relationships listed for these individuals have been mitigated.

None of the other planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Accreditation

Accreditation Statement

imageIn support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 



Credit Designation Statements

Physicians (AMA)
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 6.75 contact hour(s).  Nurses should only claim the credit commensurate with the extent of their participation in the activity.

AAPA Credit Designation Statement 
AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.  Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.  This activity is designated for 6.75 AAPA Category 1 CME credit(s).  PA’s should only claim credit commensurate with the extent of their participation. 

imageThis activity was planned by and for the healthcare team and learners will receive 6.75 Interprofessional Continuing Education.

Available Credit

  • 6.75 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.75 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 6.75 AMA PRA Category 1 Credit™
  • 6.75 ANCC Contact Hours
  • 6.75 IPCE Credit Hour(s)

Register/Take course

Please login or register to take this course.